Blueberries Medical Corp.
Blueberries Medical Corp. (BBM.CN) Financial Performance & Income Statement Overview
Explore the financials of Blueberries Medical Corp. (BBM.CN), including yearly and quarterly data on income, cash flow, and balance sheets.
Blueberries Medical Corp. (BBM.CN) Income Statement & Financial Overview
Review Blueberries Medical Corp. BBM.CN income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $265269.00 | $60969.00 | $56283.00 | $88893.00 |
| Cost of Revenue | $211594.00 | $12555.00 | $66983.00 | $94403.00 |
| Gross Profit | $53675.00 | $48414.00 | -$10700.00 | -$5510.00 |
| Gross Profit Ratio | $0.20 | $0.79 | -$0.19 | -$0.06 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $239564.00 | $233981.00 | $235443.00 | $248987.00 |
| Operating Expenses | $239564.00 | $275006.00 | $235443.00 | $248987.00 |
| Total Costs & Expenses | -$451158.00 | $287561.00 | $302426.00 | $343390.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $486.00 | $0.00 |
| Depreciation & Amortization | $27223.00 | $26558.00 | $24463.00 | $26952.00 |
| EBITDA | -$359011.00 | -$149414.00 | -$303430.00 | -$231004.00 |
| EBITDA Ratio | -$1.35 | -$2.45 | -$5.39 | -$2.60 |
| Operating Income | -$185889.00 | -$226592.00 | -$246143.00 | -$254500.00 |
| Operating Income Ratio | -$0.70 | -$3.72 | -$4.37 | -$2.86 |
| Other Income/Expenses (Net) | -$200340.00 | $50620.00 | -$82234.00 | -$30410.00 |
| Income Before Tax | -$386229.00 | -$175972.00 | -$328377.00 | -$257955.00 |
| Income Before Tax Ratio | -$1.46 | -$2.89 | -$5.83 | -$2.90 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$2.00 |
| Net Income | -$386229.00 | -$175972.00 | -$328377.00 | -$257955.00 |
| Net Income Ratio | -$1.46 | -$2.89 | -$5.83 | -$2.90 |
| EPS | -$0.001 | -$0.00 | -$0.001 | -$0.001 |
| Diluted EPS | -$0.001 | -$0.00 | -$0.001 | -$0.001 |
| Weighted Avg Shares Outstanding | $399.03M | $399.03M | $399.03M | $399.03M |
| Weighted Avg Shares Outstanding (Diluted) | $399.03M | $399.03M | $399.03M | $399.03M |
Over the last four quarters, Blueberries Medical Corp. achieved steady financial progress, growing revenue from $88893.00 in Q1 2024 to $265269.00 in Q4 2024. Gross profit stayed firm with margins at 20% in Q4 2024 versus -6% in Q1 2024. Operating income totaled -$185889.00 in Q4 2024, maintaining a -70% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$359011.00. Net income dropped to -$386229.00, with EPS at -$0.001. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan